A pilot study assessing patterns of response or resistance to preoperative dose dense docetaxel in women with newly diagnosed breast cancer.
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Docetaxel (Primary) ; Pegfilgrastim
- Indications Breast cancer; Carcinoma
- Focus Therapeutic Use
- 19 Mar 2019 Status changed from active, no longer recruiting to discontinued.
- 28 Aug 2017 Planned End Date changed from 1 Jun 2016 to 1 Jun 2018.
- 04 Nov 2016 Planned End Date changed from 1 Jul 2016 to 1 Jun 2016.